Literature DB >> 17203476

Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity.

Yangzhou Du1, Christopher P Chen, Chia-Yi Tseng, Yuval Eisenberg, Bonnie L Firestein.   

Abstract

Uric acid (UA) has been demonstrated to reduce damage to neurons elicited by oxidative stress. However, our studies utilizing cultures derived from embryonic rat spinal cord indicate that an astroglia-mediated mechanism is involved in the effects of UA to protect neurons from glutamate toxicity. The damage elicted by glutamate to neurons in a mixed culture of spinal cord cells can be reversed by UA. Furthermore, addition of UA after the termination of glutamate exposure suggests that UA plays an active role in mediating neuroprotection rather than purely binding peroxynitrite, as previously thought. Importantly, in pure neuron cultures from the same tissue, UA does not protect against glutamate toxicity. Addition of astroglia to the pure neuron cultures restores the ability of UA to protect the neurons from glutamate-induced toxicity. Our results also suggest that glia provide EAAT-1 and EAAT-2 glutamate transporters to protect neurons from glutamate, that functional EAATs may be necessary to mediate the effects of UA, and that treatment with UA results in upregulation of EAAT-1 protein. Taken together, our data strongly suggest that astroglia in mixed cultures are essential for mediating the effects of UA, revealing a novel mechanism by which UA, a naturally produced substance in the body, may act to protect neurons from damage during insults such as spinal cord injury. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17203476     DOI: 10.1002/glia.20472

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  44 in total

Review 1.  Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke.

Authors:  Laura Llull; Sergio Amaro; Ángel Chamorro
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival.

Authors:  Alice Y C Liu; Rohan Mathur; Newton Mei; Christopher G Langhammer; Bruce Babiarz; Bonnie L Firestein
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

3.  Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.

Authors:  Jeffrey K Yao; George G Dougherty; Ravinder D Reddy; Matcheri S Keshavan; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

4.  Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.

Authors:  May A Beydoun; Jose-Atilio Canas; Gregory A Dore; Hind A Beydoun; Ola S Rostant; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  J Alzheimers Dis       Date:  2016-04-21       Impact factor: 4.472

Review 5.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

6.  Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis.

Authors:  Hiroshi Mitsumoto; Diana C Garofalo; Regina M Santella; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes; Howard Andrews; Jonathan Hupf; Madison Gilmore; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Edward J Kasarskis; Catherine Lomen-Hoerth; Tahseen Mozaffar; Sharon P Nations; Andrea J Swenson; Pam Factor-Litvak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-04-10       Impact factor: 4.092

7.  Cypin: A novel target for traumatic brain injury.

Authors:  Przemyslaw Swiatkowski; Emily Sewell; Eric S Sweet; Samantha Dickson; Rachel A Swanson; Sara A McEwan; Nicholas Cuccolo; Mark E McDonnell; Mihir V Patel; Nevin Varghese; Barclay Morrison; Allen B Reitz; David F Meaney; Bonnie L Firestein
Journal:  Neurobiol Dis       Date:  2018-07-19       Impact factor: 5.996

8.  Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration.

Authors:  Xiqun Chen; Thomas C Burdett; Cody A Desjardins; Robert Logan; Sara Cipriani; Yuehang Xu; Michael A Schwarzschild
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

9.  Serum uric acid level is associated with the prevalence but not with survival of amyotrophic lateral sclerosis in a Chinese population.

Authors:  Zhenzhen Zheng; Xiaoyan Guo; Qianqian Wei; Wei Song; Bei Cao; Rui Huang; Ruwei Ou; Xueping Chen; Huifang Shang
Journal:  Metab Brain Dis       Date:  2014-03-01       Impact factor: 3.584

10.  Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database.

Authors:  Sabrina Paganoni; Katharine Nicholson; James Chan; Amy Shui; David Schoenfeld; Alexander Sherman; James Berry; Merit Cudkowicz; Nazem Atassi
Journal:  Muscle Nerve       Date:  2017-09-21       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.